Study on Predictive Factors of Anti-Angiogenesis Therapy Combined with Neoadjuvant Chemotherapy for Phase IIIA Non-Small Cell Lung Cancer

被引：0
作者：
Wang, Changli [1 ]
机构：
[1] Tianjin Med Univ, Canc Inst & Hosp, Dept Thorac Oncol, Tianjin, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
anti-angiogenesis; neoadjuvant chemotherapy; non-small cell lung cancer; Endostar; predictive factors;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PUB036
引用
收藏
页码：S771 / S771
页数：1
相关论文
共 50 条
  • [1] The actual place of anti-angiogenesis in non-small cell lung cancer
    Mennecier, B.
    REVUE DES MALADIES RESPIRATOIRES, 2007, 24 (08) : S198 - S205
  • [2] Ivonescimab in non-small cell lung cancer: harmonizing immunotherapy and anti-angiogenesis
    Zhang, Yan
    Liu, Xinyu
    Ren, Shengxiang
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2025,
  • [3] Gemcitabine combined with cisplatin as neoadjuvant chemotherapy in stage IB-IIIA non-small cell lung cancer
    Davidov, Mikhail I.
    Polotzky, Boris E.
    Marenich, Aleksander F.
    Orlov, Sergey V.
    Lazarev, Aleksander F.
    Skryabina, Lyudmila S.
    Pavlushkov, Eugeniy V.
    Semenchenya, Vladimir A.
    Brichkova, Olga Y.
    Karaseva, Vera V.
    ANTI-CANCER DRUGS, 2011, 22 (06) : 569 - 575
  • [4] Role of Anti-Angiogenesis on the Prognosis in Advanced Non-Small Cell Lung Cancer Who Are Treated with Immunotherapy
    Komiya, T.
    Huang, C.
    Neupane, P.
    Chalise, P.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2422 - S2423
  • [5] Phase II study of Neoadjuvant chemotherapy with gemcitabine and vinorelbine in resectable non-small cell lung cancer
    Ramnath, N
    Sommers, E
    Robinson, L
    Nwogu, C
    Sharma, A
    Cantor, A
    Bepler, G
    CHEST, 2005, 128 (05) : 3467 - 3474
  • [6] Stage IIIA and IIIB non-small cell lung cancer:: Results of chemotherapy combined with radiation therapy and analysis of prognostic factors
    de Cos Escuin, Julio Sanchez
    Utrabo Delgado, Isabel
    Cabrera Rodriguez, Joaquin
    Jimenez Lopez, Marcelo
    Disdier Vicente, Carlos
    Riesco Miranda, J. Antonio
    ARCHIVOS DE BRONCONEUMOLOGIA, 2007, 43 (07): : 358 - 365
  • [7] Neoadjuvant chemotherapy for stage IIIA-N2 non-small cell lung cancer
    De Marinis, Filippo
    Gebbia, V.
    De Petris, L.
    ANNALS OF ONCOLOGY, 2005, 16 : 116 - 122
  • [8] A bFGF Antagonist Peptide with Anti-angiogenesis Properties in Non-small Cell Lung Cancer Cells
    Ruixue Wang
    Wu Luo
    Xiangfeng Zeng
    Jingfang Di
    Yonglin Yu
    Chuan Wang
    Wenhui Wang
    Xilei Chen
    Dan He
    Tao Li
    Xiaoping Wu
    International Journal of Peptide Research and Therapeutics, 2013, 19 : 295 - 302
  • [9] A bFGF Antagonist Peptide with Anti-angiogenesis Properties in Non-small Cell Lung Cancer Cells
    Wang, Ruixue
    Luo, Wu
    Zeng, Xiangfeng
    Di, Jingfang
    Yu, Yonglin
    Wang, Chuan
    Wang, Wenhui
    Chen, Xilei
    He, Dan
    Li, Tao
    Wu, Xiaoping
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2013, 19 (04) : 295 - 302
  • [10] Neoadjuvant therapy for non-small cell lung cancer
    Gandara, DR
    Lara, PN
    Goldberg, Z
    Roberts, P
    Lau, DHM
    ANTI-CANCER DRUGS, 2001, 12 : S5 - S9
12345